BeaconMedaes UK has been a trusted supplier to NHS and private hospitals for over 45 years and is owned by Atlas Copco, a well-established and world-leading provider of industrial productivity solutions with over 34,000 employees globally.
As a company committed to being at the forefront of development and innovation, BeaconMedaes’ medical gas pipeline systems (MGPS) product range continues to grow in response to the UK healthcare sector’s changing needs.
The Anaesthetic Gas Scavenging System (AGSS) is an active system that extracts and disposes of waste anaesthetic gas mixtures from operating theatres and any other areas fitted with nitrous oxide terminal units, such as Maternity Departments. The removal at source eliminates the possible long-term health hazards to patients and exposed medical personnel.
The AGSS can also be used with a Central Destruction Unit (CDU) – another new addition to the comprehensive BeaconMedaes MGPS portfolio. The low-energy CDU provides sustainable gas cleaning of exhaled nitrous oxide, reducing it by over 99% by causing it to decompose rapidly into nitrogen and oxygen, the main components in air. BeaconMedaes said: “The combination of an AGSS and CDU delivers a full system solution that empowers hospitals to totally change the way they manage waste nitrous oxide gas. This not only protects the caregiver and patient, but also vastly reduces a facility’s carbon footprint, and supports the drive towards Net Zero, contributing to a cleaner, safer world.”
The BeaconMedaes CE-marked AGSS product range is now available and stocked in the company’s distribution and customer centre at Markham Vale, Derbyshire. BIM models are available to assist with plant room layout drawings, and enable the MGPS to be coordinated alongside other services. The experienced in-house team can also provide designs of medical gas pipelines to HTM 02-01 guidelines, as well as detailed 3D drawings and schematics showing sizes, equipment, and locations.
T: +44 (0)1246 474242
E: gbn.sales@ beaconmedaes.com